New developments in the treatment of asthma and chronic obstructive pulmonary disease

Immunosuppression in Chronic Asthma.

International archives of allergy and immunology·2021

Serological biomarker screening and host factor analysis elucidating immune response heterogeneity in active pulmonary tuberculosis.

Tropical biomedicine·2021

Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA.

Respiratory medicine·2017

Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients.

COPD·2009

Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial.

Respiratory medicine·2009

Initiation of maintenance treatment with salmeterol/fluticasone propionate 50/100 microg bd versus fluticasone propionate 100 microg bd alone in patients with persistent asthma: integrated analysis of four randomised trials.

Respiratory medicine·2007

Determinants of sustained smoking among individuals with chronic respiratory diseases and effects on all-cause mortality: a population-based study.

Respiratory medicine·2026

ONCOTHO-ICU : Survival prognostic factors among lung cancer patients admitted to ICU between 2021 and 2023.

Respiratory medicine·2026

Automated three-dimensional diaphragm-related surface morphometry from paired chest CT in chronic obstructive pulmonary disease.

Respiratory medicine·2026

Pulmonary response to glucagon-like peptide-1 receptor agonist therapy in adults with cystic fibrosis-related diabetes: factors associated with improvement in FEV1.

Respiratory medicine·2026

Impulse oscillometry reveals subclinical exercise-induced bronchoconstriction undetected by spirometry in healthy young adult males.

Respiratory medicine·2026

IL-5 biology and eosinophil regulation: Advances, resistance pathways and future directions.

Respiratory medicine·2026

Formulation, evaluation and characterization of fexofenadine IR and paracetamol SR multiparticulate drug delivery system.

Pakistan journal of pharmaceutical sciences·2026

The influence of the pharmaceutical industry and the pharmacy sector on Aboriginal and Torres Strait Islander health: a yarning study.

Health promotion international·2026

AI-assisted sustainable pharmaceutical bioanalysis: critical review of LC-MS, matrix effects, and white analytical chemistry.

Analytical methods : advancing methods and applications·2026

3D vascular mapping reveals multi-organ injury following severe acute pancreatitis.

Theranostics·2026

Microbial enzyme-responsive inulin nanoparticles for colon-targeted oral delivery of 5-ASA toward improved therapy of inflammatory bowel disease.

Theranostics·2026

The role of stem cells in the pharmacological assessment of nanoparticles.

Journal of pharmaceutical analysis·2026

Related Experiment Videos

New developments in the treatment of asthma and chronic obstructive pulmonary disease

Related Concept Videos

Immunosuppression in Chronic Asthma.

Serological biomarker screening and host factor analysis elucidating immune response heterogeneity in active pulmonary tuberculosis.

Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA.

Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients.

Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial.

Initiation of maintenance treatment with salmeterol/fluticasone propionate 50/100 microg bd versus fluticasone propionate 100 microg bd alone in patients with persistent asthma: integrated analysis of four randomised trials.

Determinants of sustained smoking among individuals with chronic respiratory diseases and effects on all-cause mortality: a population-based study.

ONCOTHO-ICU : Survival prognostic factors among lung cancer patients admitted to ICU between 2021 and 2023.

Automated three-dimensional diaphragm-related surface morphometry from paired chest CT in chronic obstructive pulmonary disease.

Pulmonary response to glucagon-like peptide-1 receptor agonist therapy in adults with cystic fibrosis-related diabetes: factors associated with improvement in FEV1.

Impulse oscillometry reveals subclinical exercise-induced bronchoconstriction undetected by spirometry in healthy young adult males.

IL-5 biology and eosinophil regulation: Advances, resistance pathways and future directions.

Formulation, evaluation and characterization of fexofenadine IR and paracetamol SR multiparticulate drug delivery system.

The influence of the pharmaceutical industry and the pharmacy sector on Aboriginal and Torres Strait Islander health: a yarning study.

AI-assisted sustainable pharmaceutical bioanalysis: critical review of LC-MS, matrix effects, and white analytical chemistry.

3D vascular mapping reveals multi-organ injury following severe acute pancreatitis.

Microbial enzyme-responsive inulin nanoparticles for colon-targeted oral delivery of 5-ASA toward improved therapy of inflammatory bowel disease.

The role of stem cells in the pharmacological assessment of nanoparticles.

Related Experiment Videos

New developments in the treatment of asthma and chronic obstructive pulmonary disease

Related Concept Videos

Related Articles